Structure
The Australasian Radiopharmaceutical Trials Network is governed by an Executive Committee that is responsible for overall governance, strategic planning and financial management of the Australasian Radiopharmaceutical Trials network.
The Australasian Radiopharmaceutical Trials Network Scientific Committee reports to the Executive Committee and has the key responsibility of overseeing the scientific research activities of the Network.
Executive Committee
Chair
Dr Kevin London
Immediate Past President, Australian and New Zealand Society of Nuclear Medicine
Medical Co-Head, Senior Staff Specialist, Clinical Senior Lecturer, University of Sydney Department of Nuclear Medicine, The Children’s Hospital at Westmead Sydney, Australia
Committee Members
Prof Sze Ting Lee
Immediate Past President, Australasian Association of Nuclear Medicine Specialists
Nuclear Medicine Physician and Deputy Director and Direct of Training, the PET Lead in Lymphoma and Theranostics Trials at the Department of Molecular Imaging and Therapy at Austin Health, Melbourne.
Chair of the AANMS Theranostics Committee
Nigel Lengkeek
Chair, Radiopharmaceutical Sciences Special Interest Group, Australian and New Zealand Society of Nuclear Medicine
Cyclotron Manager and Principal Radiochemist, Liverpool Hospital, SWSLHD, Sydney, NSW
Prof Roslyn Francis
Director Herston Imaging Research Facility and Senior Group Leader, AIBN, University or Queensland
Nuclear Medicine Specialist, Royal Brisbane and Women’s Hospital, Brisbane
Medical School, University of Western Australia & Dept of Nuclear Medicine and WA PET Services, Sir Charles Gairdner Hospital, Perth, WA
Prof Louise Emmett
Director of Theranostics and Nuclear Medicine at St Vincent’s Hospital Sydney, Australia
Senior Clinical Research Lead, Garvan Institute of Medical Research
Professor of Medicine (conjoint) University of New South Wales
Secretary
General Manager, Australasian Association of Nuclear Medicine Specialists
Treasurer
General Manager, Australian and New Zealand Society of Nuclear Medicine
Scientific Committee
Chair
Prof Roslyn Francis
Director Herston Imaging Research Facility and Senior Group Leader, AIBN, University or Queensland
Nuclear Medicine Specialist, Royal Brisbane and Women’s Hospital, Brisbane
Medical School, University of Western Australia & Dept of Nuclear Medicine and WA PET Services, Sir Charles Gairdner Hospital, Perth, WA
Committee Members
Bridget Chappell
Nuclear Medicine Technologist
Austin Health, Melbourne, VIC
Assoc Prof Ivan Ho Shon
Senior Staff Specialist, Department of Nuclear Medicine and PET, Prince of Wales Hospital
Conjoint Associate Professor, Discipline of Medicine, Randwick clinical Campus UNSW Medicine & Health
Prof Michael Hofman
Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC
Dr Melissa Latter
Principal Radiochemist, Department of Nuclear Medicine and Specialised PET Service
Royal Brisbane and Women’s Hospital, QLD
Dr Willam Macdonald
Head, Molecular Imaging and Therapy Service,
Fiona Stanley Hospital and Royal Perth Hospital, WA
George McGill
Chair, Physics Special Interest Group, Australia and New Zealand Society of Nuclear Medicine, Medical Physicist, Princess Alexandra Hospital, Brisbane, QLD
Assoc Prof Stuart Ramsay
Royal Brisbane and Women’s Hospital, QLD
Assoc Prof in Medicine, James Cook University, Townsville, QLD
Prof Andrew Scott
Ludwig Institute for Cancer Research, Melbourne Centre
Centre for PET, Austin Health
Olivia Newton-John Cancer Research Institute
Professor, Department of Medicine, University of Melbourne, VIC
Dr Kathy Willowson
Medical Physicist, Royal North Shore Hospital, Sydney, NSW
